Tiragolumab
Tiragolumab Basic information
- Product Name:
- Tiragolumab
- Synonyms:
-
- Tiragolumab
- Research Grade Tiragolumab(DHH72401)
- Tiragolumab (anti-TIGIT)
- RO 7092284|||RG6058-10|||MTIG-7192A|||RG6058-11|||RG-6058
- CAS:
- 1918185-84-8
- MW:
- 0
- Mol File:
- Mol File
More
Less
Tiragolumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Tiragolumab Usage And Synthesis
Description
Tiragolumab is a monoclonal antibody that targets the inhibitory receptor T-cell immunoglobulin and ITIM domain (TIGIT), which is expressed on lymphocytes and suppresses the immune response to cancer.
Uses
Tiragolumab is an investigational novel immune checkpoint inhibitor with an intact Fc region and is thought to work as an immune amplifier with other cancer immunotherapies, based on preclinical research.
TiragolumabSupplier
ShangHai Biochempartner Co.,Ltd
- Tel
- 17754423994 17754423994
- 2853530910@QQ.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354 +1-00000000000
- marketing@targetmol.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Bide Pharmatech Ltd.
- Tel
- 400-1647117 13681763483
- product02@bidepharm.com